Targeted disruption of the β1 integrin gene in a lymphoma cell line greatly reduces metastatic capacity

Cancer Research

Volumn 58, Issue 7, 1998, Pages 1569-1577

  Strocken, Peter J M ^a   Van Rijthoven, Ellen A M ^a   Van Der Valk, Martin A ^a   Roos, Ed ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; BETA1 INTEGRIN; FIBRONECTIN; HOMING RECEPTOR; LAMININ; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; GENE TARGETING; LIVER METASTASIS; LYMPHOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; ALLELE; ANIMAL; CELL ADHESION; CELL CULTURE; DBA MOUSE; GENE THERAPY; GENETICS; LIVER TUMOR; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; SPLEEN TUMOR; T CELL LYMPHOMA;

ALLELES; ANIMALS; ANTIGENS, CD29; CELL ADHESION; FIBRONECTINS; GENE THERAPY; INTEGRIN ALPHA4BETA1; INTEGRINS; LAMININ; LIVER NEOPLASMS, EXPERIMENTAL; LYMPHOMA, T-CELL; MICE; MICE, INBRED DBA; MICE, KNOCKOUT; PHENOTYPE; RECEPTORS, LYMPHOCYTE HOMING; SPLENIC NEOPLASMS; TUMOR CELLS, CULTURED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032034217     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Hynes, R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69: 11-25, 1992.
2. O'Toole, T. E., Katagiri, Y., Faull, R. J., Peter, K., Tamura, R., Quaranta, V., Loftus, J. C., Shattil, S. J., and Ginsberg, M. H. Integrin cytoplasmic domains mediate inside-out signal transduction. J. Cell Biol., 124: 1047-1059, 1994.
3. Clark, E. A., and Brugge, J. S. Integrins and signal transduction pathways: the road taken. Science (Washington DC), 268: 233-239, 1995.
4. Schwartz, M. A., Schaller, M. D., and Ginsberg, M. H. Integrins: emerging paradigms of signal transduction. Annu. Rev. Cell Dev. Biol., 11: 549-599, 1995.
5. Stetler-Stevenson, W. G., Aznavoorian, S., and Liotta, L. A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol., 9: 541-573, 1993.
6. Giancotti, F. G., and Mainiero, F. Integrin-mediated adhesion and signaling in tumorigenesis. Biochim. Biophys. Acta, 1198: 47-64, 1994.
7. Chan, B. M. C., Matsuura, N., Takada, Y., Zetter, B. R., and Hemler, M. E. In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science (Washington DC), 251: 1600-1602, 1991.
8. Qian, F., Vaux, D. L., and Weissman, I. L. Expression of the integrin α4β1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell, 77: 335-347, 1994.
9. Humphries, M. J., Yamada, K. M., and Olden, K. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells. J. Clin. Invest., 81: 782-790, 1988.
10. Ruiz, P., Dunon, D., Sonnenberg, A., and Imhof, B. A. Suppression of mouse melanoma metastasis by EA-1, a monoclonal antibody specific for α6 integrins. Cell Adhes. Commun., 1: 67-81, 1993.
11. Elliott, B. E., Ekblom, P., Pross, H., Niemann, A., and Rubin, K. Anti-β1 integrin IgG inhibits pulmonary macrometastasis and the size of micrometastases from a murine mammary carcinoma. Cell Adhes. Commun., 1: 319-332, 1994.
12. Newton, S. A., Reeves, E. J., Gralnick, H., Mohla, S., Yamada, K. M., Olden, K., and Akiyama, S. K. Inhibition of experimental metastasis of human breast carcinoma cells in athymic nude mice by anti-α5β1 fibronectin receptor integrin antibodies. Int. J. Oncol., 6: 1063-1070, 1995.
13. Roossien, F. F., de Rijk, D., Bikker, A., and Roos, E. Involvement of LFA-1 in lymphoma invasion and metastasis demonstrated with LFA-1-deficient mutants. J. Cell Biol., 108: 1979-1985, 1989.
14. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
15. Wennerberg, K., Lohikangas, L., Gullberg, D., Pfaff, M., Johansson, S., and Fässler, R. β1 integrin-dependent and -independent polymerization of fibronectin. J. Cell Biol., 132: 227-238, 1996.
16. Fässler, R., Pfaff, M., Murphy, J., Noegel, A. A., Johansson, S., Timpl, R., and Albrecht, R. Lack of β1 integrin gene in embryonic stem cells affects morphology, adhesion, and migration but not integration into the inner cell mass of blastocysts. J. Cell Biol., 128: 979-988. 1995.
17. Te Riele, H., Robanus Maandag, E., Clarke, A., Hooper, M., and Berns, A. Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells. Nature (Lond.), 348: 649-651, 1990.
18. Wu, H., Liu, X., and Jaenisch, R. Double replacement: strategy for efficient introduction of subtle mutations into the murine Colla-1 gene by homologous recombination in embryonic stem cells. Proc. Natl. Acad. Sci. USA, 91: 2819-2823, 1994.
19. Jang, S. K., and Wimmer, E. Cap-independent translation of encephalomyocarditis virus RNA: structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein. Genes Dev., 4: 1560-1572, 1990.
20. Schirrmacher, V., Shantz, G., Clauer, K., Komitowski, D., Zimmermann, H. P., and Lohmann-Matthes, M. L. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo. Int. J. Cancer, 23: 233-244, 1979.
21. Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., and Berns, A. Simplified mammalian DNA isolation procedure. Nucleic Acids Res., 19: 4293, 1991.
22. Sonnenberg, A., Daams, H., van der Valk, M., Hilkens, J., and Hilgers, J. Development of mouse mammary gland: identification of stages in differentiation of luminal and myoepithelial cells using monoclonal antibodies and polyvalent antiserum against keratin. J. Histochem. Cytochem., 34: 1037-1046, 1986.
23. Rosen, H., and Gordon, S. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. J. Exp. Med., 166: 1685-1701, 1987.
24. Miyake, K., Medina, K. L., Hayashi, S., Ono, S., Hamaoka, T., and Kincade, P. W. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J. Exp. Med., 171: 477-488, 1990.
25. Marcantonio, E. E., and Hynes, R. O. Antibodies to the conserved cytoplasmic domain of the β1 integrin subunit react with proteins in vertebrates, invertebrates, and fungi. J. Cell Biol., 106: 1765-1772, 1988.
26. Driessens, M. H. E., Van Hulten, P., Zuurbier, A., La Rivière, G., and Roos, E. Inhibition and stimulation of LFA-1 and Mac-1 functions by antibodies against murine CD18. Evidence that the LFA-1 binding sites for ICAM-1, -2 and -3 are distinct. J. Leukocyte Biol., 60: 758-765, 1996.
27. Defilippi, P., van Hinsbergh, V., Bertolotto, A., Rossino, P., Silengo, L., and Tarone, G. Differential distribution and modulation of expression of α1β1 integrin on human endothelial cells. J. Cell Biol., 114: 855-863, 1991.
28. Welder, C. A., Lee, D. H. S., and Takei, F. Inhibition of cell adhesion by micro-spheres coated with recombinant soluble intercellular adhesion molecule-1. J. Immunol., 150: 2203-2210, 1993.
29. Von Ballestrem, C. G., Uniyal, S., McCormick, J. I., Chau, T., Singh, B., and Chan, B. M. VLA-β1 integrin subunit-specific monoclonal antibodies MB1.1 and MB1.2: binding to epitopes not dependent on thymocyte development or regulated by phorbol ester and divalent cations. Hybridoma, 15: 125-132, 1996.
30. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D., and Mulligan, R. C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA, 90: 3539-3543, 1993.
31. Pear, W. S., Nolan, G. P., Scott, M. L., and Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA, 90: 8392-8396, 1993.
32. Charron, J., Malynn, B. A., Robertson, E. J., Goff, S. P., and Alt, F. W. High-frequency disruption of the N-myc gene in embryonic stem and pre-B cell lines by homologous recombination. Mol. Cell. Biol., 10: 1799-1804, 1990.
33. Buerstedde, J. M., and Takeda, S. Increased ratio of targeted to random integration after transfection of chicken B cell lines. Cell, 67: 179-188, 1991.
34. Feldhaus, A. L., Klug, C. A., Arvin, K. L., and Singh, H. Targeted disruption of the Oct-2 locus in a B cell provides genetic evidence for two distinct cell type-specific pathways of octamer element-mediated gene activation. EMBO J., 12: 2763-2772, 1993.
35. Shirasawa, S., Furuse, M., Yokoyama, N., and Sasazuki, T. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science (Washington DC), 269: 85-88, 1993.
36. Driessens, M. H. E., Stroeken, P. J. M., Rodriguez Erena, N. F., van der Valk, M. A., van Rijthoven, E. A. M., and Roos, E. Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity. J. Cell Biol., 131: 1849-1855, 1995.
37. Te Riele, H., Robanus Maandag, E., and Berns, A. Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. Proc. Natl. Acad. Sci. USA, 89: 5128-5132, 1992.
38. Doetschman, T., Maeda, N., and Smithies, O. Targeted mutation of the Hprt gene in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA, 85: 8583-8587, 1988.
39. Hanson, K. D., and Sedivy, J. M. Analysis of biological selections for high-efficiency gene targeting. Mol. Cell. Biol., 15: 45-51, 1995.
40. Kilshaw, P. J., and Murant, S. J. Expression and regulation of β7(βp) integrins on mouse lymphocytes: relevance to the mucosal immune system. Eur. J. Immunol., 21: 2591-2597, 1991.
41. Holzmann, B., McIntyre, B. W., and Weissman, I. L. Identification of a murine Peyer's patch-specific lymphocyte homing receptor as an integrin molecule with an α chain homologous to human VLA-4α. Cell. 56: 37-46, 1989.
42. Kennel, S. J., Foote, L. J., and Flynn, K. M. Tumor antigen on benign adenomas and on murine lung carcinomas quantitated by a two-site monoclonal antibody assay. Cancer Res., 46: 707-712, 1986.
43. Sonnenberg, A., Daams, H., Calafat, J., and Hilgers, J. In vitro differentiation and progression of mouse mammary tumor cells. Cancer Res., 46: 5913-5922, 1986.
44. Crowe, D. T., Chiu, H., Fong, S., and Weissman, I. L. Regulation of the avidity of integrin α4β7 by the β7 cytoplasmic domain. J. Biol. Chem., 269: 14411-14418, 1994.
45. Humphries, M. J. Integrin activation: the link between ligand binding and signal transduction. Curr. Opin. Cell Biol., 8: 632-640, 1996.
46. Schirrmacher, V., Bosslet, K., Shantz, G., Clauer, K., and Hübsch, D. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes. Int. J. Cancer, 23: 245-252, 1979.
47. Bacon, K. B., and Schall, J. T. Chemokines as mediators of allergic inflammation. Int. Arch. Immunol., 109: 97-109, 1996.
48. Mackay, C. R. Chemokine receptors and T cell chemotaxis. J. Exp. Med., 184: 799-802, 1996.
49. Förster, R., Mattis, A. E., Kremmer, E., Wolf, E., Brem, G., and Lipp, M. A putative chemokine receptor, BRL1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell, 87: 1037-1047, 1996.
50. Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A., and Springer, T. A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med., 184: 1101-1109, 1996.
51. La Rivière, G., Schipper, C. A., Collard, J. G., and Roos, E. Invasiveness in hepatocyte and fibroblast monolayers and metastatic potential of T-cell hybridomas in mice. Cancer Res., 48: 3405-3410, 1988.
52. La Rivière, G., Klein Gebbinck, J. W. T. M., Driessens, M. H. E., and Roos, E. Pertussis toxin inhibition of T-cell hybridoma invasion is reversed by manganese-induced activation of LFA-1. J. Cell Sci., 107: 551-559, 1994.
53. Driessens, M. H. E., van Rijthoven, E. A. M., La Rivière, G., and Roos, E. Expression of pertussis toxin adenosine diphosphate-ribosyltransferase in a T-cell hybridoma reduces metastatic capacity. Blood, 88: 3116-3123, 1996.
54. Hirsch, E., Iglesias, A., Potocnik, A. J., Hartmann, U., and Fässler, R. Impaired migration but not differentiation of haematopoietic stem cells in the absence of β1 integrins. Nature (Lond.), 380: 171-175, 1996.
55. Fässler, R., and Meyer, M. Consequences of lack of β1 integrin gene expression. Genes Dev., 9: 1896-1908, 1995.
56. Roos, E., Dingemans, K. P., van de Pavert, I. V., and van den Bergh-Weerman, M. A. Invasion of lymphosarcoma cells into the perfused mouse liver. J. Natl. Cancer Inst., 58: 399-407, 1977.
57. Weiss, L. The structure of intermediate vascular pathways in the spleen of rabbits. Am. J. Anat., 113: 51-65, 1963.
58. Martinez-Hernandez, A. The hepatic extracellular matrix. I. Electron immunohistochemical studies in normal rat liver. Lab. Invest., 51: 57-74. 1984.
59. Peters, J. H., Chen, G., and Hynes, R. O. Fibronectin isoform distribution in the mouse. II. Differential distribution of the alternatively spliced EIIIB, EIIIA, and V segments in the adult mouse. Cell Adhes. Commun., 4: 127-148, 1996.
60. Guan, J. L., and Hynes, R. O. Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin α4β1. Cell, 60: 53-61, 1990.
61. Swerlick, R. A., Eckman, J. R., Kumar, A., Jeitler, M., and Wick, T. M. α4β1-Integrin expression on sickle reticulocytes: vascular cell adhesion molecule-dependent binding to endothelium. Blood, 82: 1891-1900, 1993.
62. García-Barcina, M., Lukomska, B., Gawron, W., Winnock, M., Vidal-Vanaclocha, F., Bioulac-Sage, P., Balabaud, C., and Olszewski, W. Expression of cell adhesion molecules on liver-associated lymphocytes and their ligands on sinusoidal lining cells in patients with benign or malignant liver disease. Am. J. Pathol., 146: 1406-1413, 1995.
63. Yamamoto, H., Irie, A., Fukushima, Y., Ohnishi, T., Arita, N., Hayakawa, T., and Sekiguchi, K. Abrogation of lung metastasis of human fibrosarcoma cells by ribozyme-mediated suppression of integrin α6 subunit expression. Int. J. Cancer, 65: 519-524, 1996.
64. Matsuura, N., Puzon-McLaughlin, W., Irie, A., Morikawa, Y., Kakudo, K., and Takada, Y. Induction of experimental bone metastasis in mice by transfection of integrin α4β1 into tumor cells. Am. J. Pathol., 148: 55-61, 1996, 1996.
65. Gosslar, U., Jonas, P., Luz, A., Lifka, A., Naor, D., Hamann, A., and Holzmann, B. Predominant role of α4-integrins for distinct steps of lymphoma metastasis. Proc. Natl. Acad. Sci. USA, 93: 4821-4826, 1996.
66. Kilshaw, P. J., and Murant, S. J. A new surface antigen on intraepithelial lymphocytes in the intestine. Eur. J. Immunol., 20: 2201-2207, 1990.
67. Yun, Z., Menter, D. G., and Nicolson, G. L. Involvement of integrin αVβ3 in cell adhesion, motility, and liver metastasis of murine RAW117 large cell lymphoma. Cancer Res., 56: 103-111, 1996.
68. Roossien, F. F., de Kuiper, P. E., de Rijk, D., and Roos, E. Invasive and metastatic capacity of revertants of LFA-1 -deficient mutant T-cell hybridomas. Cancer Res., 50: 3509-3513, 1990.
69. Rocha, M., Umansky, V., Schirrmacher, V., and Elices, M. J. In situ downregulation of VLA-4 integrin cell surface expression during lymphoma growth and liver metastasis. Int. J. Oncol., 10: 457-464, 1997.
70. Dzarlieva, R., Schirrmacher, V., and Fusenig, N. F. Cytogenetic changes during tumor progression towards invasion, metastasis and immune escape in the Eb/ESb model system. Int. J. Cancer, 30: 633-642, 1982.